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Abstract
Background: Fatigue has not been investigated in long-term Intensive Care Unit (ICU) survivors. This study aimed
to assess fatigue through a specific instrument, namely the Functional Assessment of Chronic Illness Therapy
Fatigue (FACIT-F) scale, in ICU survivors one year after hospital discharge. A secondary aim was to compare the
findings of FACIT-F with those of the Vitality domain (VT) of the 36-item Short-Form Health Survey (SF-36).
Methods: This prospective cohort study was performed on 56 adult patients with a Length Of Stay (LOS) in ICU
longer than 72 h. At one year after hospital discharge, FACIT-F and SF-36 questionnaires were administered to
consenting patients by direct interview. FACIT-F was measured as raw (range 0–52), and FACIT-F-trans value (range
0–100). Past medical history, and demographic and clinical ICU-related variables were collected.
Results: The patients’ median age was 67.5, Simplified Acute Physiology Score II 31, and LOS in ICU 5 days.
The median raw FACIT-F of the patients was 41, and Cronbach’s α was 0.937. The correlation coefficient
between FACIT-F-trans and VT of SF-36 was 0.660 (p < 0.001). Both FACIT-F and VT were related to dyspnoea
scale (p = 0.01). A Bland-Altman plot of VT vs FACIT-F-trans showed a bias of –0.8 with 95 % limits of
agreement from 35.7 to –34.1. The linear regression between differences and means was 0.639, suggesting a
significant proportional bias.
Conclusions: The 13-item FACIT-F questionnaire is valid to assess fatigue of long-term ICU survivors. VT of
SF-36 relates to FACIT-F, but consists of only four items assessing two positive and two negative aspects.
FACIT-F grasps the negative aspects of fatigue better than VT. Specific tools assess specific conditions better
that general tools.
Trial registration: ClinicalTrials.gov: NCT02684877.
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Background
Fatigue, perceived by the individual as an overwhelming
sense of tiredness at rest, is one of the symptoms most
commonly reported by patients [1]. There are many
causes of pathological fatigue, including both neuro-
logical and non-neurological diseases. Within the last
group, cancer, infections, and drugs are factors associ-
ated with fatigue [1]. For many cancer patients, fatigue is
the most distressing untreated symptom that causes the
greatest amount of interference with daily life [2]. Can-
cer Related Fatigue affects quality of life adversely by re-
ducing mental and physical functioning, disturbing
mood, and interfering with usual activities [3]. A survey
on Australian and Canadian haematological cancer
survivors identified ‘Dealing with feeling tired’ as the
highest concern of survivors [4]. Interestingly, fatigue
continues to be a problem for breast carcinoma disease-
free survivors, 5–10 years after the diagnosis, especially for
women treated with both radiation and chemotherapy [5].
Some evidence suggest that patients who have been
critically ill continue to face a multitude of physical, psy-
chological, and social difficulties in the long term after
discharge [6]. Fatigue has not been widely explored in
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Intensive Care Unit (ICU) patients but more than 50 %
of ICU survivors reported lowered energy levels and fa-
tigue in the first year after discharge [7]. More recently,
an extensive survey on long-term complications reported
by the General Practitioners who followed ICU survivors
at one year showed that decreased exercise tolerance
and chronic fatigue were among those most often re-
ported [8], underlying the clinical relevance of chronic
fatigue in ICU survivors. However, no study has specific-
ally assessed fatigue among long-term ICU survivors
through a validated instrument.
Many instruments to measure fatigue have been pro-
posed in rheumatic conditions [9]. One of the most used
is the Functional Assessment Chronic Illness Therapy-
Fatigue (FACIT-F) scale. It was developed in 1997 to
measure fatigue in oncology patients with anaemia [10],
and has been validated in a sample of the general USA
population [11], and in patients with rheumatic diseases
[9, 12]. Recently, FACIT-F has been validated in patients
with inflammatory bowel disease [13], Chronic Obstruct-
ive Pulmonary Disease (COPD) [14, 15] and iron defi-
ciency anaemia [16], resulting in one of the most
appropriate fatigue questionnaires [17].
Many studies on validation of fatigue questionnaires
analysed the correlation between the FACIT-F and the
Vitality domain (VT) of the general 36-item Short-Form
Health Survey (SF-36) [9]. A strong correlation was
found between FACIT-F scale and VT of SF-36, though
FACIT-F items cover a wider range of fatigue than the
VT items of SF-36 [9, 16].
The aim of the present study was to measure fatigue
through a specific instrument (FACIT-F) administered
to ICU survivors one year after discharge from the hos-
pital. A secondary aim was to compare the findings of
fatigue assessed by FACIT-F with those obtained by the
VT of SF-36.
Methods
The study was conducted in a mixed medical-surgical
6-bed ICU of a university hospital of 710 beds located
in the Northeast of Italy. This ICU serves all thoracic,
vascular, and high-risk abdominal surgery patients
and about half of the medical ward patients of the
hospital.
All consecutive adult ICU patients discharged between
March 2013 and October 2014 were considered for en-
rolment. We included patients aged more than 18 years,
staying in ICU for at least 72 h, without pre-existing
cognitive dysfunction or language barrier. One year after
hospital discharge, we assessed the vital status of the pa-
tients through the Vital Statistics Offices. We excluded
patients residing farther than 30 km from the hospital,
and we contacted the ICU survivors by phone to ask
them to participate in the study. Those who agreed
received an appointment at the hospital for a date and
time convenient for them.
The demographics and clinical data of the study pa-
tients were retrieved from the ICU database. The soft-
ware for this (PROSAFE) is made available by the Italian
GiViTI group, and has been used in the study ICU since
2008 for daily collection and storage of patient data. For
each participant, the following information was re-
trieved: gender, age, Body Mass Index (BMI), pre-
existing comorbidities (like hypertension, COPD, cardiac
failure of NYHA class III or IV, and diabetes), reason for
ICU admission, type of admission (elective surgery,
emergency surgery, or medical admission), date of hos-
pital and ICU admission, presence of severe sepsis or
septic shock (at ICU admission or during ICU stay),
main treatments received (administration of vasoactive
amines, mechanical ventilation, renal replacement tech-
niques), date of ICU and hospital discharge and vital sta-
tus at hospital discharge. The following computed data
were also retrieved: Simplified Acute Physiology Score
(SAPS) II [18] and Sequential Organ Failure Assessment
(SOFA) Score [19] which referred to the first 24 h in
ICU, and Length Of Stay (LOS) referring to the number
of days in ICU and in hospital after ICU discharge.
Instruments
At the time of the appointment at the hospital, a re-
searcher not involved in the care of the patient during
his/her stay in ICU welcomed the patient, obtained
signed consent, and administered the following ques-
tionnaires in a calm and confidential environment. The
time scheduled for each appointment was 30 min and it
was generally observed.
The Functional Assessment of Chronic Illness Therapy
for Fatigue (FACIT-F) scale is a sub-scale of a general
questionnaire developed to assess anaemia-related symp-
toms in cancer patients [10]. FACIT-F consists of 13
items referring to the previous seven days. Each item al-
lows five response options from ‘Not at all’ (scored 4) to
‘Very much’ (scored 0) with two items needing a reverse
score. The scores are summed, multiplied by 13, then di-
vided by the number of items actually answered, thereby
allowing calculation for missing items. The final (raw)
score ranges from 0 to 52, with higher scores represent-
ing less fatigue, and lower scores more fatigue. The raw
scores can be transformed into interval measures
(FACIT-F-trans) ranging from 0 to 100, according to an
interval metric proposed by Cella et al. [11].
The Short-Form 36 (SF-36 version 1) [20] was admin-
istered in the previously validated Italian version [21].
The questionnaire refers to the four previous weeks, and
consists of eight multi-item dimensions, i.e., physical
functioning (PF), role limitation due to physical prob-
lems (RP), bodily pain (BP), general health (GH), vitality
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(VT), social functioning (SF), role limitation due to emo-
tional problems (RE), and mental health (MH). Scores
with a range from 0 to 100 are obtained for each dimen-
sion. Higher scores represent better functioning. Differ-
ences in SF-36 scores of more than 5 points were
reported as clinically meaningful [22].
The Medical Research Council Dyspnoea (MRCD) Scale
is suitable to assess the extent to which breathlessness af-
fects patient mobility during daily activities [23]. It con-
sists of five statements about perceived breathlessness,
from grade 1 (breathless with strenuous exercise) to grade
5 (too breathless to leave the house). We administered the
MRCD Scale to check for a correlation between this scale
and both FACIT-F and VT of SF-36. We predicted that
FACIT-F scores would be significantly worse (lower) in
patients with mobility affected by breathlessness than in
those without it. This analysis was performed to demon-
strate the construct validity of both FACIT-F and VT.
The Ethics Committee of the Province of Ferrara ap-
proved the study protocol (n. 140696), and required the
written consent of each participant. We received permis-
sion for the appointed institution to use the FACIT-F
and SF-36 questionnaires.
Statistics
Categorical data are presented as count (%). The Shapiro-
Wilk test was used to assess whether continuous variables
were normally distributed, and data are shown as mean
(±SD), or median with 1st and 3rd quartiles [Q1-Q3], ac-
cordingly. A Chi squared test, or a Fisher’s exact test when
appropriate, was used for categorical comparisons, and a
Mann-Whitney U test for comparisons of non-normally
distributed variables. We investigated the internal
consistency of the FACIT-F questionnaire using Cron-
bach’s α coefficient. Spearman’s correlation coefficient was
used to analyse correlations between FACIT-F and VT of
Fig. 1 Flowchart of the study patients
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SF-36, and between both FACIT-F and VT and the MRCD
Scale. The Bland Altman plot was used to assess the
agreement between FACIT-F-Trans and VT of SF-36
(both ranging 0-100). Linear regression between the differ-
ences and the means, which should be close to zero, was
used to evaluate the presence of a proportional bias.
For each SF-36 dimension, we computed the normal
values for a population matched to our study patients
for gender and age [24], and we compared mean values
of our study patients with the Italian adjusted normative
population using an unpaired t test.
A Type I error in two-tailed tests was considered sig-
nificant (α 0.05). Statistical analysis was performed using
the software packages SPSS v. 11.5 (IBM, New York,
USA) and STATA 12.1 (StataCorp, Texas, USA).
Due to the lack of studies specifically assessing fatigue
in long-term ICU survivors, we relied on the raw values
of FACIT-F (43.6 ± 9.4) for the general USA population
[11]. To detect a 10 % difference (4.36) between the
mean score of our patients and that of the general USA
population (α = 0.05, power = 0.80), the necessary sample
size was calculated as 37 patients. Considering that
Table 1 Clinical characteristics of the patients interviewed and missing the interview (refusals excluded). Data are shown as median
with quartiles [Q1-Q3]. Categorical data are reported as number with percentage in brackets
Interviewed Missing the interview p value*
Patients, n (%) 56 59
Gender male, n (%) 38 (67.8) 39 (66.1) 0.844
Age, years, median [Q1-Q3] 67.5 [59.0-74.0] 73 [62.7-77.0] 0.214
Body Mass Index, kg/m2, median [Q1-Q3] 26.8 [23.5-30.6] 24.7 [22.1-27.3] 0.018
Comorbidities, n (%)
absent 14 (25.0) 18 (30.5) 0.798
one 25 (44.6) 25 (42.4)
more than one 17 (30.4) 16 (27.1)
Type of ICU admission, n (%)
Medical 20 (35.7) 24 (40.7) 0.612
Urgent surgical 24 (42.9) 20 (33.9)
Elective surgical 12 (21.4) 15 (25.4)
Diagnostic group, n (%)
Respiratory pathology 17 (30.4) 25 (42.4) 0.793
Cardiovascular pathology 9 (16.0) 8 (13.6)
Gastrointestinal pathology 25 (44.6) 21 (35.6)
Neurological pathology 3 (5.4) 1 (1.7)
Trauma 1 (1.8) 1 (1.7)
Other 1 (1.8) 2 (3.4)
SAPS II score, median [Q1-Q3] 31 [27.0-37.7] 33 [26.0-48.2] 0.231
SOFA score, median [Q1-Q3] 4.0 [3.0-6.0] 4.0 [2.0-8.0] 0.389
Severe sepsis/septic shock, n (%)
at ICU admission 15 (26.8) 16 (27.1) 0.568
during ICU stay 18 (32.1) 19 (32.2) 0.994
Treatments received in ICU
Mechanical ventilation, n (%) 48 (85.7) 47 (79.7) 0.465
Duration of MV a, days, median [Q1-Q3] 3 [1.2-9.0] 4 [2.0-10.2] 0.328
Vasoactive amines, n (%) 13 (23.2) 22 (37.3) 0.110
Renal Replacement Treatment, n (%) 1 (1.8) 1 (1.7) 0.970
LOSb in ICU, days, median [Q1-Q3] 5 [3.0-12.0] 7 [5.0-12.2] 0.012
LOSb in hospital, days, median [Q1-Q3] 10.5 [7.0-17.0] 8.5 [5.0-15.5] 0.103
*p value: statistical significance
aMV mechanical ventilation
bLOS length of stay
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long-term mortality and dropouts could markedly de-
crease the number of the patients who can be assessed
at one year, we decided that the time hypothetically re-
quested for reaching the sample size was about
16 months (March 2013 - October 2014).
Results
During the study period, 439 patients were discharged
from the ICU alive (Fig. 1). Two hundred and forty of
them, who stayed in ICU less than 72 h, as well as 6 pa-
tients with a pre-existing cognitive disorder and 4 pa-
tients with language barriers, were excluded. Of the
remaining 189 patients, 25 died in hospital after ICU
discharge, and 34 were dead at one year according to the
Vital Statistics Offices. Of the 130 patients alive one year
after ICU discharge, 15 refused to participate in the
study, and no information about them was collected.
Thirty-nine patients who lived farther than 30 km from
the hospital, 12 patients who were not found despite mul-
tiple attempts to contact them, six patients hospitalized at
one year, and two homeless people could not be inter-
viewed. At one year, we directly interviewed 56 patients.
The clinical characteristics of the study group and of
the 59 patients who missed the interview (Fig. 1) are re-
ported in Table 1. The two groups showed a statistically
significant difference in the BMI and in the LOS in ICU.
Of the patients assessed at one year (mean age 67.0 ±
10.6 y), only 25 % had no comorbidity. While 36 of the
study admissions were surgical (64.3 %), with 24 urgent
and 12 elective admissions, the other 20 admissions were
medical (35.7 %). The most common reasons for ICU
admission were acute respiratory failure (48) and severe
sepsis or septic shock (15) amounting to 85.7 % and
26.8 % respectively. Forty-eight patients (85.7 %) received
mechanical ventilation (mean duration 6.5 ± 9.8 days,
range 1-54), and 13 (23.2 %) received vasoactive amines.
The mean raw FACIT-F score of the study patients
was 39.1 (±10.1, median 41, Q1-Q3 34-47), and the
FACIT-F-trans value was 66.4 (±12.4, median 66, Q1-Q3
59-74). Cronbach’s α of FACIT-F was 0.937. The correl-
ation coefficient between the FACIT-F-trans and the VT
of SF-36 was 0.660 (p < 0.001). The Bland Altman plot of
FACIT-F-Trans vs VT showed a bias of -0.8 with 95 %
limits of agreement from -34.1 to 35.7 (Fig. 2). The lin-
ear regression between differences and means was 0.639,
suggesting a significant proportional bias.
The SF-36 data for the study group and the adjusted
Italian population [24] are reported in Table 2. The radar
chart for the study group and the adjusted Italian nor-
mal population is shown in Fig. 3.
Eighteen patients (32 %) reported a perceived breath-
lessness grade of one (normal value) on the MRCD
Scale. Of the remaining patients, 17 (30 %) were in the
second grade, 10 (18 %) in the third, 8 (14 %) in the
fourth and 3 (6 %) in the fifth grade of the MRCD Scale.
The correlation coefficient between the MRCD Scale
and FACIT-F-Trans was -0.593 (p = 0.01), and that be-
tween the MRCD Scale and VT was -0.430 (p = 0.01).
Fig. 2 Bland-Altman plot to assess the agreement between FACIT-F-Trans and Vitality dimension (VT) of SF-36. Each marker represents one
patient. The x-axis shows the mean value of the two assessments and the y-axis shows the difference between the two assessments. The solid line
represents the overall mean difference, and the dashed lines represents the 95 % limits of agreement (1.96 SD mean difference). Where perfect
agreement is observed, individual points line up along the 0 line of the y-axis
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Discussion
Chronic fatigue is distressing and greatly interferes with
daily activities. It may result from depression but can
also cause it, and however worsens the quality of life of
patients and their families. Assessing fatigue by a vali-
dated instrument is important because it may allow phy-
sicians to take care of the patients with chronic fatigue
and their families.
Our study patients reported a value of fatigue, assessed
by the FACIT-F scale, not too far from that of the gen-
eral USA population (median 41 vs 47) [11]. The
FACIT-F-trans values were significantly related to the
VT of SF-36 (Spearman’s rho 0.660). The VT dimension
of SF-36 reported by these patients was better than that
of the adjusted Italian population (mean 65.6 vs 55.3),
both statistically (p = 0.001), and clinically (because it
was higher than 5 points [22]). The Bland-Altman plot
of SF-36 VT versus FACIT-F-trans showed a small bias
(-0.8), but wide limits of agreement and proportional
bias.
This is the first study where the FACIT-F question-
naire was administered to former ICU patients. One year
after hospital discharge, the mean raw FACIT-F score,
which has a range 0-52, was 39.1 ± 10.1. The mean raw
values reported in studies performed in different settings
ranged from 29.1 [25] to 35.8 [12] in rheumatologic dis-
eases, from 24 ± 11 in iron deficiency anaemia [16] to
23.9 ± 12.6 in anaemic cancer patients [11], and from
40.0 ± 9.8 in non-anaemic cancer patients [11] to 43.6 ±
9.4 in a sample of the general USA population [11].
Therefore, fatigue reported by our study patients was
lower than that reported in studies performed in pa-
tients, and more similar to that of a normal USA
population.
As far as validation of FACIT-F is concerned, Cron-
bach’s α of 0.937 for our patients was high, and similar
to that reported by others [12, 13, 16]. This finding indi-
cates good reliability of the questionnaire, whose ques-
tions are likely to measure the same construct.
Moreover, the FACIT-F values did not show a floor or
ceiling effect (data not shown). We also tested the con-
struct validity considering that the grade of the MRCD
scale should be related to fatigue, and we found that
FACIT-F was significantly related to the MRCD scale.
Therefore, we can conclude that the FACIT-F question-
naire is valid for ICU survivors assessed at one year.
The secondary aim of our study was to verify whether
the VT domain of SF-36, which is widely used in the as-
sessment of ICU patients at follow-up, could substitute
the most specific FACIT-F questionnaire. We found a
good correlation between FACIT-F-trans (range 0-100),
and VT of SF-36 (rho 0.660, p < 0.001). The Bland
Altman plot showed a bias of -0.8 with 95 % limits of
agreement from -34.1 to 35.7. These wide limits of
Table 2 Short Form-36 data of the study patients shown as
mean, Standard Deviation (SD), median and quartiles [Q1-Q3].
For each SF-36 dimension, the values for the study patients
and the normative values are reported, with delta value (mean
of study patients –normative mean). Negative delta values
represent a quality of life of the study patients worse than that
of the normal population
Study patients Normative valuesa Delta p value *
SF-36b
































a Data of the Italian normative sample collected by Apolone et al. [24]
adjusted for gender and age
bPF physical functioning, RP role limitation due to physical problems, BP bodily
pain, GH general health, VT vitality, SF social functioning, RE role limitation due
to emotional problems, MH mental health (range 0-100 with higher scores rep-
resent better functioning)
*p value: statistical significance according to unpaired t test
** Delta value showing a minimum clinically significant difference of more
than 5 points, consistent with quality of life worse than the adjusted
normal population
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agreement, and the significant proportional bias found
by the linear regression suggest that VT does not allow
an accurate assessment of fatigue. The reason for this
discrepancy between correlation and agreement of
FACIT-F and VT may depend on the items assessed by
each questionnaire. The FACIT-F consists of 13 items,
assessing 11 negative and 2 positive aspects (An5 ‘I have
energy’, and An7 ‘I am able to do my usual activities’),
while the VT of SF-36 consists of 4 items, that assess 2
positive and 2 negative aspects. We can hypothesize that
FACIT-F may grasp the negative aspects of fatigue better
than VT.
The VT of SF-36 in our patients was clinically better
than that of the adjusted Italian normal population [24].
In detail, values clinically worse (mean of study patients
minus normative mean > 5) than that of the adjusted
Italian normal population were found for RP, while clin-
ically better values were found for BP, GH, and MH di-
mensions (Table 2). Many studies assessing quality of
life at one year by SF-36, in mixed ICU patients of differ-
ent countries, generally found values of SF-36 dimen-
sions clinically lower than that of the adjusted normal
population [26–31]. Hence, our patients experienced a
relatively good quality of life one year after hospital dis-
charge, comparable to that of the adjusted Italian normal
population. We do not have an explanation for this find-
ing. Nevertheless, Chiumello et al. [32], who evaluated
26 Italian ARDS patients ventilated in supine or prone
position at the one-year stage, had similar results. Inter-
estingly, the assessments of both our patients and those
of Chiumello et al. [32] were performed by direct inter-
view at the hospital, and the percentages of the eligible
patients assessed were 43 % and 39 %, respectively. We
excluded patients residing farther than 30 km from the
hospital, and Chiumello et al. [32] excluded patients res-
iding more than 40 km from the hospital. Of the 15 pa-
tients (11.5 %) who refused to participate, some claimed
that they had difficulty in reaching the hospital. There-
fore, the assessment of patients at the hospital may cre-
ate a selection bias. An alternative hypothesis is that the
Italian normative sample, collected in 1995 [24], may
not be suitable for comparisons after 20 years. Indeed,
the country with the world's second highest life expect-
ancy in 2012 and 2013 [33], has a relatively healthy cuis-
ine and diet, and a good healthcare system. Possibly, all
these factors may have positively affected health-related
quality of life over time, with better actual normal values
than in the past.
This study has strengths and limitations. As far as the
former are concerned, the comparison between the pa-
tients interviewed and those missing the interview
showed no statistically significant differences, except for
BMI and LOS in ICU, which were slightly different
(Table 1). Therefore, our findings should be of general
value although we cannot rule out any undetected selec-
tion bias. The exclusion of patients living over 30 km
from the hospital is a limitation, and we do not know
whether some refusals may mask any symptoms related
to Post Traumatic Stress Disorder [34]. Collecting data
by direct interview allowed us to have very little missing
Fig. 3 Comparison between the mean values of the dimensions of Short-Form 36 reported by the study patients and those of the Italian adjusted
(ADJ) normative population using unpaired t test. PF: physical functioning; RP: role limitation due to physical problems; BP bodily pain; GH: general
health; VT: vitality; SF: social functioning; RE: role limitation due to emotional problems; MH: mental health
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data (33 of 2744 items, 0.01 %), and guarantees the ab-
sence of interference from family members or other per-
sons in the answers to the questionnaires. Moreover, it
allowed all patients to give their written informed con-
sent to the study, as required by the Ethics Committee.
Conclusions
This study validates the 13-item FACIT-F scale to assess
fatigue in ICU survivors one year after hospital dis-
charge. The Vitality dimension of SF-36 correlates with
the FACIT-F scale, but consists of only four items asses-
sing two positive and two negative aspects of vitality.
FACIT-F grasps the negative aspects of fatigue better
than the Vitality dimension of SF-36. Specific tools as-
sess specific conditions better that general tools. This in-
formation should be useful for future studies designed to
investigate fatigue in former ICU patients.
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